Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole

[1]  B. Cohen,et al.  Exposure to the Selective κ-Opioid Receptor Agonist Salvinorin A Modulates the Behavioral and Molecular Effects of Cocaine in Rats , 2008, Neuropsychopharmacology.

[2]  D. Ferguson,et al.  Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor. , 2008, Journal of medicinal chemistry.

[3]  P. Seeman,et al.  Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). , 2007, Behavioral neuroscience.

[4]  J. Foster,et al.  Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats , 2007, Psychopharmacology.

[5]  Jonathan Appel,et al.  The Rise of a New Psychoactive Agent: Salvia divinorum , 2007, International Journal of Mental Health and Addiction.

[6]  J. Riba,et al.  Pattern of use and subjective effects of Salvia divinorum among recreational users. , 2006, Drug and alcohol dependence.

[7]  H. Szechtman,et al.  Kappa-Opioid Agonist U69593 Potentiates Locomotor Sensitization to the D2/D3 Agonist Quinpirole: Pre- and Postsynaptic Mechanisms , 2006, Neuropsychopharmacology.

[8]  M. Greenberg,et al.  Emerging drugs of abuse. , 2005, The Medical clinics of North America.

[9]  Ulrike Holzgrabe,et al.  Comparison of Pharmacological Activities of Three Distinct κ Ligands (Salvinorin A, TRK-820 and 3FLB) on κ Opioid Receptors in Vitro and Their Antipruritic and Antinociceptive Activities in Vivo , 2005, Journal of Pharmacology and Experimental Therapeutics.

[10]  B. Roth,et al.  Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. , 2003, Trends in pharmacological sciences.

[11]  Bryan L. Roth,et al.  Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Szumlinski,et al.  Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency , 1997, Psychopharmacology.

[13]  D. Eilam,et al.  Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism , 1994, Psychopharmacology.

[14]  W. Butler,et al.  Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum , 1984 .

[15]  Paul Ernsberger,et al.  Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Alfredo Ortega,et al.  Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae) , 1982 .

[17]  R. Wasson.  A New Mexican Psychotropic Drug from the Mint Family , 1962, Botanical Museum leaflets, Harvard University.